0001209191-11-043960.txt : 20110812 0001209191-11-043960.hdr.sgml : 20110812 20110812144718 ACCESSION NUMBER: 0001209191-11-043960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110811 FILED AS OF DATE: 20110812 DATE AS OF CHANGE: 20110812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carmine Bryce D. CENTRAL INDEX KEY: 0001430788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 111030864 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-08-11 0 0000059478 LILLY ELI & CO LLY 0001430788 Carmine Bryce D. LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 EVP and Pres, Lilly Bio-Meds Common Stock 2011-08-11 4 S 0 5700 33.94 D 74298 D Common Stock 6669 I 401(k) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. This transaction was executed in multiple trades at prices ranging from $33.90 to $34.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. See attached footnotes page. Bronwen Mantlo for Bryce D. Carmine, authorization on file 2011-08-12